China Medical System Holdings Limited (0867.HK)
HKD 7.36
(-0.67%)
HKD 7.36
(-0.67%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.1 Billion CNY | -13.17% |
| 2022 | 7.03 Billion CNY | 12.63% |
| 2021 | 6.24 Billion CNY | 21.67% |
| 2020 | 5.13 Billion CNY | 12.93% |
| 2019 | 4.54 Billion CNY | 16.07% |
| 2018 | 3.91 Billion CNY | 12.61% |
| 2017 | 3.47 Billion CNY | 19.45% |
| 2016 | 2.91 Billion CNY | 42.31% |
| 2015 | 2.04 Billion CNY | 23.66% |
| 2014 | 1.65 Billion CNY | 37.84% |
| 2013 | 1.2 Billion CNY | 15.99% |
| 2012 | 1.03 Billion CNY | 38.23% |
| 2011 | 748.67 Million CNY | 44.53% |
| 2010 | 518.02 Million CNY | 24.66% |
| 2009 | 415.53 Million CNY | 36.03% |
| 2008 | 305.47 Million CNY | 24.46% |
| 2007 | 245.43 Million CNY | 21.35% |
| 2006 | 202.25 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.34 Billion CNY | 9.17% |
| 2024 Q2 | 1.34 Billion CNY | 0.0% |
| 2023 Q1 | 1.8 Billion CNY | 0.17% |
| 2023 FY | 6.1 Billion CNY | -13.17% |
| 2023 Q4 | 1.23 Billion CNY | 0.0% |
| 2023 Q3 | 1.23 Billion CNY | -31.5% |
| 2023 Q2 | 1.8 Billion CNY | 0.0% |
| 2022 Q1 | 1.71 Billion CNY | 1.87% |
| 2022 FY | 7.03 Billion CNY | 12.63% |
| 2022 Q4 | 1.79 Billion CNY | 0.0% |
| 2022 Q3 | 1.79 Billion CNY | 4.76% |
| 2022 Q2 | 1.71 Billion CNY | 0.0% |
| 2021 Q3 | 1.68 Billion CNY | 17.38% |
| 2021 FY | 6.24 Billion CNY | 21.67% |
| 2021 Q1 | 1.43 Billion CNY | 1.16% |
| 2021 Q4 | 1.68 Billion CNY | 0.0% |
| 2021 Q2 | 1.43 Billion CNY | 0.0% |
| 2020 Q3 | 1.42 Billion CNY | 23.87% |
| 2020 FY | 5.13 Billion CNY | 12.93% |
| 2020 Q1 | 1.14 Billion CNY | -1.52% |
| 2020 Q2 | 1.14 Billion CNY | 0.0% |
| 2020 Q4 | 1.42 Billion CNY | 0.0% |
| 2019 Q1 | 1.1 Billion CNY | 9.07% |
| 2019 Q3 | 1.16 Billion CNY | 5.02% |
| 2019 Q4 | 1.16 Billion CNY | 0.0% |
| 2019 FY | 4.54 Billion CNY | 16.07% |
| 2019 Q2 | 1.1 Billion CNY | 0.0% |
| 2018 Q2 | 941.85 Million CNY | 0.0% |
| 2018 Q4 | 1.01 Billion CNY | 0.0% |
| 2018 FY | 3.91 Billion CNY | 12.61% |
| 2018 Q1 | 941.85 Million CNY | 3.71% |
| 2018 Q3 | 1.01 Billion CNY | 7.93% |
| 2017 Q1 | 830.98 Million CNY | 1.19% |
| 2017 FY | 3.47 Billion CNY | 19.45% |
| 2017 Q4 | 908.16 Million CNY | 0.0% |
| 2017 Q3 | 908.16 Million CNY | 9.29% |
| 2017 Q2 | 830.98 Million CNY | 0.0% |
| 2016 FY | 2.91 Billion CNY | 42.31% |
| 2016 Q1 | 634.75 Million CNY | 16.67% |
| 2016 Q2 | 634.75 Million CNY | 0.0% |
| 2016 Q3 | 821.19 Million CNY | 29.37% |
| 2016 Q4 | 821.19 Million CNY | 0.0% |
| 2015 Q4 | 544.08 Million CNY | 0.0% |
| 2015 FY | 2.04 Billion CNY | 23.66% |
| 2015 Q2 | 478.96 Million CNY | 0.0% |
| 2015 Q1 | 478.96 Million CNY | 4.38% |
| 2015 Q3 | 544.08 Million CNY | 13.6% |
| 2014 Q2 | 368.44 Million CNY | 0.0% |
| 2014 Q1 | 368.44 Million CNY | 11.21% |
| 2014 FY | 1.65 Billion CNY | 37.84% |
| 2014 Q4 | 458.86 Million CNY | 0.0% |
| 2014 Q3 | 458.86 Million CNY | 24.54% |
| 2013 Q3 | 331.31 Million CNY | 17.54% |
| 2013 Q4 | 331.31 Million CNY | 0.0% |
| 2013 FY | 1.2 Billion CNY | 15.99% |
| 2013 Q1 | 281.87 Million CNY | 1.18% |
| 2013 Q2 | 281.87 Million CNY | 0.0% |
| 2012 FY | 1.03 Billion CNY | 38.23% |
| 2012 Q2 | - CNY | -100.0% |
| 2012 Q1 | 296.66 Million CNY | 0.0% |
| 2012 Q3 | 280.99 Million CNY | 0.0% |
| 2012 Q4 | 278.57 Million CNY | -0.86% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 FY | 748.67 Million CNY | 44.53% |
| 2011 Q4 | - CNY | 0.0% |
| 2010 FY | 518.02 Million CNY | 24.66% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 FY | 415.53 Million CNY | 36.03% |
| 2008 FY | 305.47 Million CNY | 24.46% |
| 2007 FY | 245.43 Million CNY | 21.35% |
| 2006 FY | 202.25 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 167.43 Million HKD | -3548.657% |
| Grand Pharmaceutical Group Limited | 6.52 Billion HKD | 6.36% |
| Extrawell Pharmaceutical Holdings Limited | 28.77 Million HKD | -21127.861% |
| Wai Yuen Tong Medicine Holdings Limited | 394.81 Million HKD | -1447.357% |
| Qianhai Health Holdings Limited | -35.6 Million HKD | 17259.133% |
| Lee's Pharmaceutical Holdings Limited | 551.31 Million HKD | -1008.116% |
| Essex Bio-Technology Limited | 1.53 Billion HKD | -296.881% |
| Tongfang Kontafarma Holdings Limited | 471.29 Million HKD | -1196.259% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -2720.105% |
| SSY Group Limited | 3.48 Billion HKD | -75.089% |
| JBM (Healthcare) Limited | 319.41 Million HKD | -1812.605% |
| Jacobson Pharma Corporation Limited | 620.47 Million HKD | -884.595% |
| China Resources Pharmaceutical Group Limited | 43.36 Billion HKD | 85.913% |